Want to see BBIO full AI Analyst Report?

BridgeBio Pharma (BBIO) Revenue

1,515 Followers

BridgeBio Pharma Revenue

BridgeBio Pharma had a revenue of 222.44M in the quarter ending Jun 30, 2026, with 14.36%. This bring the company's revenue in the last twelve months to 691.84M, Decreased 19.29%. In the fiscal year ending Dec 31, 2025, BridgeBio Pharma had annual revenue of 502.08M with 126.26% growth.

Revenue (ttm)

691.84M

Revenue Growth

202.39%

P/S Ratio

31.09

Revenue/Employee

$598,424

Employees

839

Market Cap

$15.61B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	502.08M	280.18M	+126.26%
Dec 31, 2024	221.90M	212.60M	+2,285.27%
Dec 31, 2023	9.30M	-68.34M	-88.02%
Dec 31, 2022	77.65M	7.93M	+11.38%
Dec 31, 2021	69.72M	61.47M	+745.14%
Dec 31, 2020	8.25M	-32.31M	-79.66%
Dec 31, 2019	40.56M	―	+∞%
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―